Lenoxin® (Digoxin)

Digoxin inhibits the Na⁺/K⁺‑ATPase pump in cardiac cells, raising intracellular sodium and consequently calcium levels. This enhances the force of contraction and increases vagal tone, slowing conduction through the atrioventricular node and helping to regulate heart rhythm.

The specific dose of digoxin is individualized by the prescribing clinician based on factors such as age, kidney function, body weight, and serum electrolyte status. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data are limited; digoxin should only be used during pregnancy or lactation if the potential benefit justifies the possible risk to the fetus or infant. The prescriber will evaluate the risk‑benefit profile for each patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Digoxin provides a unique positive inotropic effect and rate‑control benefit that differs from ACE inhibitors, beta‑blockers, or diuretics, which mainly reduce workload or fluid overload. It is often added when symptoms persist despite standard therapy, but its narrow therapeutic window requires careful monitoring.

Store Lenoxin® at room temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Lenoxin® is taken orally, usually with or without food, as directed by the prescriber. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

The most serious risks include cardiac arrhythmias such as ventricular tachycardia or severe bradycardia, heart block, and digoxin toxicity manifested by nausea, visual disturbances, and confusion. Prompt medical attention is required if any of these symptoms occur.

Patients with ventricular fibrillation, advanced atrioventricular block without a pacemaker, severe renal impairment, or uncontrolled electrolyte abnormalities should generally avoid digoxin. The prescriber will assess individual contraindications before initiating therapy.